Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study.

Kogure Y, Hashimoto H, Ikeda S, Harada T, Hino A, Miura S, Goto Y, Fujiwara K, Katakami N, Kubota K, Murata N, Mori M, Abe T, Saito AM, Yamamoto N, Saka H, Kondo M.

Open source

DOI: 10.1016/j.ctarc.2026.101094
Published: 2026-01-02
Container: Cancer Treat Res Commun
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101094,
  title = {Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study.},
  author = {Kogure Y and  Hashimoto H and  Ikeda S and  Harada T and  Hino A and  Miura S and  Goto Y and  Fujiwara K and  Katakami N and  Kubota K and  Murata N and  Mori M and  Abe T and  Saito AM and  Yamamoto N and  Saka H and  Kondo M.},
  year = {2026},
  journal = {Cancer Treat Res Commun},
  doi = {10.1016/j.ctarc.2026.101094},
  url = {https://doi.org/10.1016/j.ctarc.2026.101094}
}

RIS

TY  - JOUR
TI  - Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study.
AU  - Kogure Y
AU  -  Hashimoto H
AU  -  Ikeda S
AU  -  Harada T
AU  -  Hino A
AU  -  Miura S
AU  -  Goto Y
AU  -  Fujiwara K
AU  -  Katakami N
AU  -  Kubota K
AU  -  Murata N
AU  -  Mori M
AU  -  Abe T
AU  -  Saito AM
AU  -  Yamamoto N
AU  -  Saka H
AU  -  Kondo M.
PY  - 2026
JO  - Cancer Treat Res Commun
DO  - 10.1016/j.ctarc.2026.101094
UR  - https://doi.org/10.1016/j.ctarc.2026.101094
ER  -

APA

Y, K., H, H., S, I., T, H., A, H., S, M., Y, G., K, F., N, K., K, K., N, M., M, M., T, A., AM, S., N, Y., H, S., & M., K. (2026). Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study.. Cancer Treat Res Commun. https://doi.org/10.1016/j.ctarc.2026.101094

Source records

europe-pmc · retrieved 2026-09-27T10:44:58.929Z
doaj · retrieved 2026-09-27T10:44:58.942Z